NTLA Intellia Therapeutics | $9.50
+0.8% | 10/27/2020 | Initiated by | Summer Street | - | Buy | | High | View details for Summer Street rating of Intellia Therapeutics (NASDAQ:NTLA) on 10/27/2020 |
AMD Advanced Micro Devices | $121.46
+2.5% | 1/29/2020 | Upgraded by | Summer Street | - | Neutral -> Buy | | High | View details for Summer Street rating of Advanced Micro Devices (NASDAQ:AMD) on 1/29/2020 |
EBS Emergent BioSolutions | $9.91
-0.7% | 3/6/2015 | Reiterated by | Summer Street | - | Buy | $35.00 | N/A | View details for Summer Street rating of Emergent BioSolutions (NYSE:EBS) on 3/6/2015 |
RMTI Rockwell Medical | $2.12
+1.0% | 1/27/2015 | Target Set by | Summer Street | Analyst James Molloy | Positive -> Buy | $275.00 | N/A | View details for Summer Street rating of Rockwell Medical (NASDAQ:RMTI) on 1/27/2015 |
CARA Cara Therapeutics | $4.65
+1.1% | 12/9/2014 | Initiated by | Summer Street | - | Buy | $240.00 | N/A | View details for Summer Street rating of Cara Therapeutics (NASDAQ:CARA) on 12/9/2014 |
RMTI Rockwell Medical | $2.12
+1.0% | 11/4/2014 | Reiterated by | Summer Street | Analyst James Molloy | Positive | | N/A | View details for Summer Street rating of Rockwell Medical (NASDAQ:RMTI) on 11/4/2014 |
RMTI Rockwell Medical | $2.12
+1.0% | 9/12/2014 | Reiterated by | Summer Street | Analyst James Molloy | Buy | | N/A | View details for Summer Street rating of Rockwell Medical (NASDAQ:RMTI) on 9/12/2014 |
SNN Smith & Nephew | $25.33
+1.1% | 6/5/2014 | Target Raised by | Summer Street | - | Buy | $100.00 -> $112.00 | N/A | View details for Summer Street rating of Smith & Nephew (NYSE:SNN) on 6/5/2014 |
IONS Ionis Pharmaceuticals | $31.43
-2.6% | 5/23/2014 | Reiterated by | Summer Street | - | Neutral | | N/A | View details for Summer Street rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 5/23/2014 |
ZBH Zimmer Biomet | $109.65
+0.7% | 5/19/2014 | Upgraded by | Summer Street | - | Neutral -> Buy | $133.00 | N/A | View details for Summer Street rating of Zimmer Biomet (NYSE:ZBH) on 5/19/2014 |
|
EBS Emergent BioSolutions | $9.91
-0.7% | 5/15/2014 | Initiated by | Summer Street | - | Buy | $35.00 | N/A | View details for Summer Street rating of Emergent BioSolutions (NYSE:EBS) on 5/15/2014 |
BMY Bristol-Myers Squibb | $56.35
0.0% | 4/25/2014 | Target Lowered by | Summer Street | - | Buy | $102.50 -> $92.00 | N/A | View details for Summer Street rating of Bristol-Myers Squibb (NYSE:BMY) on 4/25/2014 |
AVDL Avadel Pharmaceuticals | $7.75
-3.1% | 4/9/2014 | Initiated by | Summer Street | - | Positive -> Buy | $25.00 | N/A | View details for Summer Street rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 4/9/2014 |
BMY Bristol-Myers Squibb | $56.35
0.0% | 3/19/2014 | Target Raised by | Summer Street | - | Buy | $90.00 -> $102.50 | N/A | View details for Summer Street rating of Bristol-Myers Squibb (NYSE:BMY) on 3/19/2014 |
NWBO Northwest Biotherapeutics | $0.28
+4.9% | 3/11/2014 | Target Raised by | Summer Street | - | Buy | $10.33 -> $15.10 | N/A | View details for Summer Street rating of Northwest Biotherapeutics (OTCMKTS:NWBO) on 3/11/2014 |
ANIK Anika Therapeutics | $16.07
-0.7% | 2/26/2014 | Target Raised by | Summer Street | - | Buy | $47.00 -> $60.00 | N/A | View details for Summer Street rating of Anika Therapeutics (NASDAQ:ANIK) on 2/26/2014 |
LGND Ligand Pharmaceuticals | $111.89
+0.7% | 2/24/2014 | Target Raised by | Summer Street | - | Buy | $78.00 -> $91.00 | N/A | View details for Summer Street rating of Ligand Pharmaceuticals (NASDAQ:LGND) on 2/24/2014 |
SNN Smith & Nephew | $25.33
+1.1% | 2/24/2014 | Target Raised by | Summer Street | - | Buy | $80.00 -> $83.00 | N/A | View details for Summer Street rating of Smith & Nephew (NYSE:SNN) on 2/24/2014 |
RMTI Rockwell Medical | $2.12
+1.0% | 2/13/2014 | Reiterated by | Summer Street | - | Buy | | N/A | View details for Summer Street rating of Rockwell Medical (NASDAQ:RMTI) on 2/13/2014 |
GILD Gilead Sciences | $91.84
+0.2% | 2/5/2014 | Reiterated by | Summer Street | - | Buy | | N/A | View details for Summer Street rating of Gilead Sciences (NASDAQ:GILD) on 2/5/2014 |
LGND Ligand Pharmaceuticals | $111.89
+0.7% | 1/27/2014 | Target Raised by | Summer Street | - | Buy | $69.00 -> $78.00 | N/A | View details for Summer Street rating of Ligand Pharmaceuticals (NASDAQ:LGND) on 1/27/2014 |
IMUC EOM Pharmaceuticals | $0.16
+0.1% | 12/12/2013 | Reiterated by | Summer Street | - | Buy | | N/A | View details for Summer Street rating of EOM Pharmaceuticals (OTCMKTS:IMUC) on 12/12/2013 |
LGND Ligand Pharmaceuticals | $111.89
+0.7% | 11/22/2013 | Target Raised by | Summer Street | - | | $69.00 | N/A | View details for Summer Street rating of Ligand Pharmaceuticals (NASDAQ:LGND) on 11/22/2013 |
RMTI Rockwell Medical | $2.12
+1.0% | 11/6/2013 | Reiterated by | Summer Street | - | Buy | $275.00 | N/A | View details for Summer Street rating of Rockwell Medical (NASDAQ:RMTI) on 11/6/2013 |
ANIK Anika Therapeutics | $16.07
-0.7% | 11/1/2013 | Target Raised by | Summer Street | - | Buy | $28.00 -> $35.00 | N/A | View details for Summer Street rating of Anika Therapeutics (NASDAQ:ANIK) on 11/1/2013 |
VRTX Vertex Pharmaceuticals | $422.00
+1.2% | 10/30/2013 | Downgraded by | Summer Street | - | Buy -> Neutral | | N/A | View details for Summer Street rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 10/30/2013 |
NWBO Northwest Biotherapeutics | $0.28
+4.9% | 9/19/2013 | Initiated by | Summer Street | - | Buy | $10.33 | N/A | View details for Summer Street rating of Northwest Biotherapeutics (OTCMKTS:NWBO) on 9/19/2013 |
EXAS Exact Sciences | $51.74
+2.6% | 9/16/2013 | Initiated by | Summer Street | - | Buy | | N/A | View details for Summer Street rating of Exact Sciences (NASDAQ:EXAS) on 9/16/2013 |
RMTI Rockwell Medical | $2.12
+1.0% | 9/5/2013 | Target Raised by | Summer Street | - | Buy | $220.00 -> $275.00 | N/A | View details for Summer Street rating of Rockwell Medical (NASDAQ:RMTI) on 9/5/2013 |
AMGN Amgen | $272.11
+1.0% | 8/26/2013 | Downgraded by | Summer Street | - | Neutral | | N/A | View details for Summer Street rating of Amgen (NASDAQ:AMGN) on 8/26/2013 |
RMTI Rockwell Medical | $2.12
+1.0% | 8/2/2013 | Reiterated by | Summer Street | - | Buy | $220.00 | N/A | View details for Summer Street rating of Rockwell Medical (NASDAQ:RMTI) on 8/2/2013 |
LGND Ligand Pharmaceuticals | $111.89
+0.7% | 8/2/2013 | Target Raised by | Summer Street | - | Buy | $36.00 -> $64.00 | N/A | View details for Summer Street rating of Ligand Pharmaceuticals (NASDAQ:LGND) on 8/2/2013 |
ANIK Anika Therapeutics | $16.07
-0.7% | 8/2/2013 | Target Raised by | Summer Street | - | Buy | $20.00 -> $28.00 | N/A | View details for Summer Street rating of Anika Therapeutics (NASDAQ:ANIK) on 8/2/2013 |
ZBH Zimmer Biomet | $109.65
+0.7% | 1/30/2013 | Downgraded by | Summer Street | - | Buy -> Neutral | | N/A | View details for Summer Street rating of Zimmer Biomet (NYSE:ZBH) on 1/30/2013 |
BMY Bristol-Myers Squibb | $56.35
0.0% | 1/23/2013 | Target Raised by | Summer Street | - | Buy | $41.50 -> $61.00 | N/A | View details for Summer Street rating of Bristol-Myers Squibb (NYSE:BMY) on 1/23/2013 |
PBYI Puma Biotechnology | $2.97
-1.7% | 11/15/2012 | Downgraded by | Summer Street | - | Neutral | | N/A | View details for Summer Street rating of Puma Biotechnology (NASDAQ:PBYI) on 11/15/2012 |
BMRN BioMarin Pharmaceutical | $61.53
+0.5% | 11/6/2012 | Target Raised by | Summer Street | - | Buy | $52.00 -> $69.00 | N/A | View details for Summer Street rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 11/6/2012 |
UTHR United Therapeutics | $358.93
-2.0% | 10/24/2012 | Downgraded by | Summer Street | - | Buy -> Neutral | | N/A | View details for Summer Street rating of United Therapeutics (NASDAQ:UTHR) on 10/24/2012 |
IONS Ionis Pharmaceuticals | $31.43
-2.6% | 10/17/2012 | Downgraded by | Summer Street | - | Buy -> Neutral | | N/A | View details for Summer Street rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 10/17/2012 |
BMRN BioMarin Pharmaceutical | $61.53
+0.5% | 9/28/2012 | Target Raised by | Summer Street | - | Buy | $45.00 -> $52.00 | N/A | View details for Summer Street rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 9/28/2012 |
Buy this coin BEFORE Inauguration Day … (Ad) Mark my words … Bitcoin is going to $100,000.
BEFORE Trump is inaugurated.
And I think it could reach $125,000 by the end of his first month in office. This could be his favorite coin. |
VRTX Vertex Pharmaceuticals | $422.00
+1.2% | 5/8/2012 | Reiterated by | Summer Street | - | Buy | | N/A | View details for Summer Street rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 5/8/2012 |
RMTI Rockwell Medical | $2.12
+1.0% | 4/11/2012 | Initiated by | Summer Street | - | Buy | $220.00 | N/A | View details for Summer Street rating of Rockwell Medical (NASDAQ:RMTI) on 4/11/2012 |
CRIS Curis | $3.29
+3.5% | 1/31/2012 | Target Raised by | Summer Street | - | Buy | $500.00 -> $700.00 | N/A | View details for Summer Street rating of Curis (NASDAQ:CRIS) on 1/31/2012 |
LGND Ligand Pharmaceuticals | $111.89
+0.7% | 1/13/2012 | Initiated by | Summer Street | - | Buy | $22.00 | N/A | View details for Summer Street rating of Ligand Pharmaceuticals (NASDAQ:LGND) on 1/13/2012 |
GILD Gilead Sciences | $91.84
+0.2% | 11/22/2011 | Downgraded by | Summer Street | - | Buy -> Neutral | | N/A | View details for Summer Street rating of Gilead Sciences (NASDAQ:GILD) on 11/22/2011 |
BMRN BioMarin Pharmaceutical | $61.53
+0.5% | 10/31/2011 | Target Raised by | Summer Street | - | Buy | $32.00 -> $40.00 | N/A | View details for Summer Street rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 10/31/2011 |
BMY Bristol-Myers Squibb | $56.35
0.0% | 10/28/2011 | Target Raised by | Summer Street | - | | $44.50 | N/A | View details for Summer Street rating of Bristol-Myers Squibb (NYSE:BMY) on 10/28/2011 |
CRIS Curis | $3.29
+3.5% | 10/6/2011 | Initiated by | Summer Street | - | Buy | $500.00 | N/A | View details for Summer Street rating of Curis (NASDAQ:CRIS) on 10/6/2011 |
ANIK Anika Therapeutics | $16.07
-0.7% | 9/19/2011 | Initiated by | Summer Street | - | Buy | | N/A | View details for Summer Street rating of Anika Therapeutics (NASDAQ:ANIK) on 9/19/2011 |
ATEC Alphatec | $11.57
+2.5% | 9/19/2011 | Initiated by | Summer Street | - | Buy | | N/A | View details for Summer Street rating of Alphatec (NASDAQ:ATEC) on 9/19/2011 |
AMGN Amgen | $272.11
+1.0% | 8/23/2011 | Initiated by | Summer Street | - | Buy | $49.00 | N/A | View details for Summer Street rating of Amgen (NASDAQ:AMGN) on 8/23/2011 |
BMY Bristol-Myers Squibb | $56.35
0.0% | 8/17/2011 | Target Raised by | Summer Street | - | Buy | $33.50 -> $35.50 | N/A | View details for Summer Street rating of Bristol-Myers Squibb (NYSE:BMY) on 8/17/2011 |
GILD Gilead Sciences | $91.84
+0.2% | 8/16/2011 | Target Raised by | Summer Street | - | Buy | $42.00 -> $54.00 | N/A | View details for Summer Street rating of Gilead Sciences (NASDAQ:GILD) on 8/16/2011 |
IMUC EOM Pharmaceuticals | $0.16
+0.1% | 7/28/2011 | Initiated by | Summer Street | - | Buy | $8.00 | N/A | View details for Summer Street rating of EOM Pharmaceuticals (OTCMKTS:IMUC) on 7/28/2011 |
VRTX Vertex Pharmaceuticals | $422.00
+1.2% | 5/24/2011 | Target Raised by | Summer Street | - | Buy | $46.00 -> $72.00 | N/A | View details for Summer Street rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 5/24/2011 |
